ORX Surgical Inc.: federal grants and contributions: 9 agreements; $1.1M value; 2 departments; 5 programs.
Assay record ASY-CA-0JE91UK062 · Cite as: Assay Systems, “ORX Surgical Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/orx-surgical-inc/
This project will support the firm to develop a HIPAA-compliant desktop web application with a smart workflow that will speed transactions between trading partners for implantable medical devices (vendors and surgical centres) and enable a reduction in days sales outstanding.
ORX will develop a surgical supply revenue cycle module that identifies revenue leakage for provider-based organizations.
This project addresses an inefficiency in the US healthcare system related to procuring surgical implants. The project will assist the firm to develop a minimum viable software product in the form of a two-sided (hospital and medical device vendor) procurement platform. The platform will address the inefficiencies in the procurement process through automation and will provide improved information security through all aspects of the transaction.
This project will help the firm develop a non-scalable, proof-of-concept Physician Preference Item (PPI) cost management tool for containing the costs of surgical procedures in hospitals related to PPI choices and PPI waste.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.